PubRank

S F Leung

Author PubWeight™ 110.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2004 3.59
2 Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005 3.14
3 Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 2002 3.11
4 Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999 2.87
5 Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2005 2.30
6 Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 1999 1.82
7 A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995 1.82
8 Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 1996 1.73
9 Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck 2000 1.71
10 Staging of nasopharyngeal carcinoma: suggestions for improving the current UICC/AJCC Staging System. Clin Oncol (R Coll Radiol) 2004 1.65
11 Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst Rev 2006 1.58
12 Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography--an analysis of 659 patients. Radiother Oncol 1992 1.52
13 Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996 1.46
14 Caution on the use of altered fractionation for nasopharyngeal carcinoma. Radiother Oncol 1999 1.43
15 Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res 2000 1.42
16 Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy. Cancer 2001 1.42
17 The clinical efficacy of neoadjuvant chemotherapy in squamous esophageal cancer: a prospective nonrandomized study of pulse and continuous-infusion regimens with Cisplatin and 5-Fluorouracil. Ann Surg Oncol 2002 1.38
18 Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem 1999 1.35
19 A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma. Ann Oncol 2011 1.29
20 Late radiation injury to the temporal lobes: morphologic evaluation at MR imaging. Radiology 1999 1.29
21 Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 1996 1.21
22 Clinically underdetected asymptomatic and symptomatic carotid stenosis as a late complication of radiotherapy in Chinese nasopharyngeal carcinoma patients. Head Neck 2001 1.19
23 Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005 1.17
24 The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol 2008 1.15
25 Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012 1.14
26 Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Med Dosim 2007 1.14
27 Dysphagia in treated nasopharyngeal cancer. Head Neck 2000 1.13
28 Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging. Ann N Y Acad Sci 2000 1.12
29 Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. J Clin Oncol 2004 1.11
30 High frequency ultrasound assessment of skin fibrosis: clinical results. Ultrasound Med Biol 2007 1.10
31 Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int J Cancer 1998 1.10
32 A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 1994 1.10
33 Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res 2000 1.10
34 CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells. J Immunol 2000 1.09
35 Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose. Int J Radiat Oncol Biol Phys 2000 1.08
36 Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation. Int J Cancer 1999 1.03
37 Novel intertypic recombinants of epstein-barr virus in the chinese population. J Virol 2000 1.00
38 Reliability of measurement of skin ultrasonic properties in vivo: a potential technique for assessing irradiated skin. Skin Res Technol 2007 1.00
39 Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res 1996 0.97
40 Carotid intima-media thickness in patients with head and neck irradiation for the treatment of nasopharyngeal carcinoma. Clin Radiol 2002 0.97
41 Prevalence and prognostic significance of tumor-associated tissue eosinophilia in nasopharyngeal carcinoma. Cancer 1996 0.97
42 Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Head Neck 1997 0.97
43 Progress of memory function after radiation therapy in patients with nasopharyngeal carcinoma. J Neuropsychiatry Clin Neurosci 2003 0.95
44 Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int J Cancer 1999 0.95
45 Segmentation of nasopharyngeal carcinoma (NPC) lesions in MR images. Int J Radiat Oncol Biol Phys 2005 0.94
46 Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer 1996 0.92
47 The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol 1994 0.91
48 Serum fatty acid, lipid profile and dietary intake of Hong Kong Chinese omnivores and vegetarians. Eur J Clin Nutr 2000 0.91
49 MRI and CT of metastatic hepatocellular carcinoma causing spinal cord compression. Clin Radiol 1997 0.90
50 Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol 2000 0.90
51 Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res 1994 0.89
52 Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphisms. Ann Oncol 2009 0.89
53 MRI of local disease in nasopharyngeal carcinoma: tumour extent vs tumour stage. Br J Radiol 1999 0.89
54 Sonographic characterisation of radiation-induced carotid artery stenosis. Cerebrovasc Dis 2002 0.89
55 Proton magnetic resonance spectroscopy of late delayed radiation-induced injury of the brain. J Magn Reson Imaging 1999 0.88
56 Failure patterns and factors affecting prognosis of salivary gland carcinoma: retrospective study. Hong Kong Med J 2000 0.88
57 A comparison of Ho's, International Union Against Cancer, and American Joint Committee stage classifications for nasopharyngeal carcinoma. Cancer 1991 0.88
58 An analysis of the incidence and risk factors of developing severe keratopathy in eyes after megavoltage external beam irradiation. Ophthalmology 1998 0.88
59 Early swallowing problems in a cohort of patients with nasopharyngeal carcinoma: Symptomatology and videofluoroscopic findings. Laryngoscope 2007 0.88
60 Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold. Eur J Cancer 1997 0.88
61 Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study. Ann Surg Oncol 2007 0.87
62 A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma. Clin Oncol (R Coll Radiol) 2007 0.87
63 Assessment of neck tissue fibrosis using an ultrasound palpation system: a feasibility study. Med Biol Eng Comput 2000 0.86
64 A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma. Cancer 2000 0.86
65 Neck ultrasound in staging squamous oesophageal carcinoma - a high yield technique. Clin Radiol 2000 0.86
66 Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 2000 0.86
67 Hypoglossal nerve palsy in nasopharyngeal carcinoma. Head Neck 1999 0.86
68 Paranasopharyngeal space involvement in nasopharyngeal cancer: detection by CT and MRI. Clin Oncol (R Coll Radiol) 2000 0.85
69 Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma. Br J Radiol 1994 0.85
70 Adjuvant chemoradiation for gastric cancer: experience in the Chinese population. Clin Oncol (R Coll Radiol) 2007 0.84
71 Improved local control for early T-stage nasopharyngeal carcinoma--a tale of two hospitals. Radiother Oncol 2000 0.83
72 Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma. Br J Radiol 1996 0.82
73 Angiographic features, collaterals, and infarct topography of symptomatic occlusive radiation vasculopathy: a case-referent study. Stroke 2013 0.82
74 A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients. Clin Oncol (R Coll Radiol) 1996 0.82
75 Magnetic resonance imaging of the eustachian tube in nasopharyngeal carcinoma: correlation of patterns of spread with middle ear effusion. Am J Otol 1999 0.82
76 Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT. Br J Radiol 1999 0.81
77 Echography of metastatic nodes treated by radiotherapy. J Laryngol Otol 1999 0.81
78 Increased incidence of tongue cancer after primary radiotherapy for nasopharyngeal carcinoma--the possibility of radiation carcinogenesis. Eur J Cancer 1999 0.81
79 Submental metastases from nasopharyngeal carcinoma. Clin Radiol 1999 0.81
80 Middle ear effusions after radiotherapy: correlation with pre-radiotherapy nasopharyngeal tumor patterns. Am J Otol 2000 0.80
81 Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life. Support Care Cancer 2009 0.80
82 Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor. Br J Cancer 1999 0.80
83 The sonographic appearance and significance of cervical metastatic nodes following radiotherapy for nasopharyngaeal carcinoma. Clin Radiol 1996 0.80
84 Lack of expression for the suppressor PML in human small cell lung carcinoma. Int J Cancer 2000 0.80
85 Breakfast practices in the Asian region. Asia Pac J Clin Nutr 1993 0.79
86 Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma. Cancer Chemother Pharmacol 1996 0.79
87 Comparison of T2 weighted fat suppressed turbo spin echo and contrast enhanced T1 weighted spin echo MRI in nasopharyngeal carcinoma. Br J Radiol 1997 0.79
88 A patient-reported outcome instrument to assess the impact of oropharyngeal mucositis on health-related quality of life: a longitudinal psychometric evaluation. Support Care Cancer 2008 0.78
89 In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. AJNR Am J Neuroradiol 2004 0.78
90 Dynamic susceptibility contrast-enhanced perfusion MR imaging in late radiation-induced injury of the brain. Acta Neurochir Suppl 2005 0.78
91 A comparison of wound treatments in nasopharyngeal cancer patients receiving radiation therapy. Cancer Nurs 2005 0.78
92 Magnetic resonance imaging and audiologic assessment of middle ear effusions in patients with nasopharyngeal carcinoma before radiation therapy. Am J Otol 1999 0.77
93 Abnormalities of the paranasal sinuses in patients with nasopharyngeal carcinoma: a computed tomographic study. J Laryngol Otol 1996 0.77
94 Review of a new root canal obturation technique. Dent Update 1994 0.77
95 Combined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable non-small-cell lung cancer. Oncology 1992 0.77
96 Epstein-Barr virus in oropharyngeal and nasopharyngeal secretions of patients with nasopharyngeal carcinoma and control subjects. Intervirology 1991 0.77
97 Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007 0.77
98 Functional experiential hallucinosis after radiotherapy for nasopharyngeal carcinoma. J Neurol Neurosurg Psychiatry 1998 0.77
99 Depuration of metals from soft tissues of oysters (Crassostrea gigas) transplanted from a contaminated site to clean sites. Environ Pollut 1999 0.77
100 MR features of the denervated tongue in radiation induced neuropathy. Br J Radiol 1999 0.76
101 Use of Rasch analysis in the evaluation of the Oropharyngeal Mucositis Quality Of Life Scale. Nurs Res 2011 0.76
102 Oropharyngeal mucositis-specific quality-of-life measure in patients with cancer therapy. Hong Kong Med J 2010 0.76
103 Surgical result of radiation-induced cataract in Chinese patients with nasopharyngeal carcinoma. Dev Ophthalmol 1994 0.76
104 Secular trends in head growth. Arch Dis Child 1986 0.76
105 Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079). Invest New Drugs 2015 0.76
106 In vivo diagnosis of nasopharyngeal carcinoma using contact rhinoscopy. Laryngoscope 2001 0.76
107 New measure of health-related quality of life for patients with oropharyngeal mucositis: development and preliminary psychometric evaluation. Cancer 2007 0.75
108 Expression of beta-2-microglobulin by nasopharyngeal carcinoma. Br J Cancer 1992 0.75
109 A nasal mask for the Chinese (Rodrigo-Leung mask). Anesth Prog 1988 0.75
110 A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC). Eur J Cancer B Oral Oncol 1995 0.75
111 Differential expression of the suppressor PML and Ki-67 identifies three subtypes of human nasopharyngeal carcinoma. Eur J Cancer 2002 0.75
112 A retrospective comparison between different stage classifications for nasopharyngeal carcinoma. Br J Radiol 1991 0.75
113 Nasopharyngeal carcinoma: dynamic MR imaging with gadolinium. Chin Med J (Engl) 1998 0.75
114 Will sex selection reduce fertility? J Popul Econ 1994 0.75
115 Afterloading intracavitary radiation treatment of nasopharyngeal carcinoma. Description of a technique and preliminary treatment results. Acta Oncol 1989 0.75
116 The volumetric relationship of white matter lesion and contrast-enhanced lesion in delayed radiation brain injury: an MRI-based study. Br J Neurosurg 2013 0.75
117 Differences in perceptions of coronary disease among Hong Kong Chinese: implications for the societal readiness in disease prevention. Psychol Health Med 2011 0.75
118 Feasibility of using interpolated contours of targets and organs at risk in intensity-modulated radiation therapy treatment planning for advanced-stage nasopharyngeal carcinoma. Australas Radiol 2007 0.75
119 On tests for sex preferences. J Popul Econ 1988 0.75
120 Clinical encounter experiences of patients with nasopharyngeal carcinoma. Integr Cancer Ther 2008 0.75
121 Thoracic metastases from carcinoma of the nasopharynx: high frequency of hilar and mediastinal lymphadenopathy. AJR Am J Roentgenol 1993 0.75
122 Strong association between hyperferritinaemia and metastatic disease in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol 1996 0.75
123 Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: a study based on CT scanning. Clin Oncol (R Coll Radiol) 1994 0.75
124 Radiotherapy for extreme hypertrophic pulmonary osteoarthropathy associated with malignancy. Clin Oncol (R Coll Radiol) 1996 0.75
125 Conservative management of a radicular cyst associated with a non-vital tooth. Dent Update 1996 0.75
126 Prognostic significance of argyrophilic nucleolar organizer regions in nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 2000 0.75
127 High-dose-rate remote afterloading irradiation of carcinoma of the cervix in Hong Kong: unexpectedly high complication rate. Clin Oncol (R Coll Radiol) 1992 0.75
128 Replace axis-orbital pointer with level pointer in facebow transfer. J Prosthet Dent 1992 0.75
129 Attitudes of Hong Kong medical students toward different modalities of treatment for cancer. Psychol Rep 1995 0.75
130 Soft tissue sarcoma: the experience of a regional hospital in Hong Kong. Clin Oncol (R Coll Radiol) 1992 0.75
131 Metastatic adenopathy from nasopharyngeal carcinoma: successful response to radiation therapy assessed by color duplex sonography. AJNR Am J Neuroradiol 1999 0.75
132 The paranasal sinuses before and after radiotherapy for nasopharyngeal carcinoma: a computed tomographic study. J Laryngol Otol 1996 0.75
133 Auditory brainstem responses after radiotherapy for nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci 1997 0.75
134 Neovascular glaucoma developing after uncomplicated cataract surgery for heavily irradiated eyes. Ophthalmology 1997 0.75